TCL Archive Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint November 25, 2011
TCL Archive Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC September 3, 1999